Matches in Nanopublications for { ?s ?p "[Macrolide resistance in Helicobacter pylori is the major risk factor for treatment failure when using a proton pump inhibitor-clarithromycin containing therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- NP526886.RAWqDyh3opkxGnr7MVFDy2uS4aAU5DgshVMfAsmzqtnts130_assertion description "[Macrolide resistance in Helicobacter pylori is the major risk factor for treatment failure when using a proton pump inhibitor-clarithromycin containing therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP526886.RAWqDyh3opkxGnr7MVFDy2uS4aAU5DgshVMfAsmzqtnts130_provenance.
- NP256256.RAapJk9O7uyWJNyEypUXWlBXmmynxhQnLaCvLgmGEWt_M130_assertion description "[Macrolide resistance in Helicobacter pylori is the major risk factor for treatment failure when using a proton pump inhibitor-clarithromycin containing therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP256256.RAapJk9O7uyWJNyEypUXWlBXmmynxhQnLaCvLgmGEWt_M130_provenance.
- NP256650.RAB00UF227ABRuoW1nQlJYYKs9wYBQK50F4eoDdj95qQA130_assertion description "[Macrolide resistance in Helicobacter pylori is the major risk factor for treatment failure when using a proton pump inhibitor-clarithromycin containing therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP256650.RAB00UF227ABRuoW1nQlJYYKs9wYBQK50F4eoDdj95qQA130_provenance.
- NP931558.RABmVJZYqbztBKoV946JQVSUZAvvNQ_sFi-mJd46_KE4A130_assertion description "[Macrolide resistance in Helicobacter pylori is the major risk factor for treatment failure when using a proton pump inhibitor-clarithromycin containing therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP931558.RABmVJZYqbztBKoV946JQVSUZAvvNQ_sFi-mJd46_KE4A130_provenance.
- NP931559.RAn4ojNuyHxku2IJ8lQMnmKVGbcsYTV1AS9jD180EuG0U130_assertion description "[Macrolide resistance in Helicobacter pylori is the major risk factor for treatment failure when using a proton pump inhibitor-clarithromycin containing therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP931559.RAn4ojNuyHxku2IJ8lQMnmKVGbcsYTV1AS9jD180EuG0U130_provenance.